PATENTS

7. Callmann, C.E., Thompson, M.T., Gianneschi, N.C., LeGuyader, C.L., Bertin, P.A. “Modified Cytotoxins and Their Therapeutic Use.” US10286079. Filed March 22, 2017. Granted May 14, 2019.

6. Ahmad, M., Day, T.P., Callmann, C.E., Zhu, Z., Hafez, I. “Mucus-Penetrating Peptides, Delivery Vehicles and Methods of Therapy.” WO2019222400A2. Filed May 5, 2018. Published November 21, 2019.

5. Callmann, C.E., Thompson, M.T., Gianneschi, N.C., LeGuyader, C.L., Bertin, P.A. “Modified Cytotoxins and Their Therapeutic Use.” US10023581B2. Filed September 21, 2016. Granted July 7, 2018.

4. LeGuyader, C.L., Gianneschi, N.C., Callmann, C.E., Thompson, M.P., Ditri, T. “Modified MRI Contrast Agents and Uses Thereof.” WO2018200615A2. Filed April 25, 2018. Published November 11, 2018.

3. Thompson, M.T., Gianneschi, N.C., Bertin, P.A., Callmann, C.E. “Modified Peptides and Uses Thereof for Treating Cancer.” WO2018175589A1. Filed March 21, 2018. Published September 27, 2018.

2. Roloff, A., Gianneschi, N.C., Callmann, C.E., Thompson, M.P. “Modified Oligonucleotides and Therapeutic Uses Thereof.” WO2018175592A1. Filed March 21, 2018. Published September 27, 2018.

1. Gianneschi, N.C., Callmann, C.E., Thompson, M.P. Bertin, P.A. “Modified Anthracycline Compounds and Their Therapeutic Use.” WO2018175622A1. Filed March 21, 2018. Published September 27, 2018.

 

©2020 by Cassandra Callmann, Ph.D.